Medical Care

Global Neuropathy Pain Treatment Market Research Report 2026

This report delivers a comprehensive overview of the global Neuropathy Pain Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neuropathy Pain Treatment. The Neuropathy Pain Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Neuropathy Pain Treatment market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Neuropathy Pain Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
Depomed
Eli Lilly
Endo
Grünenthal Group
Arbor Pharmaceuticals
Segment by Type
Calcium Channel Alpha 2-delta Ligands
Serotonin-norepinephrine Reuptake Inhibitors
Others
Segment by Application
Retail Pharmacies
Hospitals
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Neuropathy Pain Treatment companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuropathy Pain Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Calcium Channel Alpha 2-delta Ligands
1.2.3 Serotonin-norepinephrine Reuptake Inhibitors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Neuropathy Pain Treatment Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Retail Pharmacies
1.3.3 Hospitals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuropathy Pain Treatment Market Perspective (2021–2032)
2.2 Global Neuropathy Pain Treatment Growth Trends by Region
2.2.1 Global Neuropathy Pain Treatment Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Neuropathy Pain Treatment Historic Market Size by Region (2021–2026)
2.2.3 Neuropathy Pain Treatment Forecasted Market Size by Region (2027–2032)
2.3 Neuropathy Pain Treatment Market Dynamics
2.3.1 Neuropathy Pain Treatment Industry Trends
2.3.2 Neuropathy Pain Treatment Market Drivers
2.3.3 Neuropathy Pain Treatment Market Challenges
2.3.4 Neuropathy Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuropathy Pain Treatment Players by Revenue
3.1.1 Global Top Neuropathy Pain Treatment Players by Revenue (2021–2026)
3.1.2 Global Neuropathy Pain Treatment Revenue Market Share by Players (2021–2026)
3.2 Global Top Neuropathy Pain Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Neuropathy Pain Treatment Revenue
3.4 Global Neuropathy Pain Treatment Market Concentration Ratio
3.4.1 Global Neuropathy Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuropathy Pain Treatment Revenue in 2025
3.5 Global Key Players of Neuropathy Pain Treatment Head Offices and Areas Served
3.6 Global Key Players of Neuropathy Pain Treatment, Products and Applications
3.7 Global Key Players of Neuropathy Pain Treatment, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Neuropathy Pain Treatment Breakdown Data by Type
4.1 Global Neuropathy Pain Treatment Historic Market Size by Type (2021–2026)
4.2 Global Neuropathy Pain Treatment Forecasted Market Size by Type (2027–2032)
5 Neuropathy Pain Treatment Breakdown Data by Application
5.1 Global Neuropathy Pain Treatment Historic Market Size by Application (2021–2026)
5.2 Global Neuropathy Pain Treatment Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Neuropathy Pain Treatment Market Size (2021–2032)
6.2 North America Neuropathy Pain Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Neuropathy Pain Treatment Market Size by Country (2021–2026)
6.4 North America Neuropathy Pain Treatment Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuropathy Pain Treatment Market Size (2021–2032)
7.2 Europe Neuropathy Pain Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Neuropathy Pain Treatment Market Size by Country (2021–2026)
7.4 Europe Neuropathy Pain Treatment Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Neuropathy Pain Treatment Market Size (2021–2032)
8.2 Asia-Pacific Neuropathy Pain Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Neuropathy Pain Treatment Market Size by Region (2021–2026)
8.4 Asia-Pacific Neuropathy Pain Treatment Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Neuropathy Pain Treatment Market Size (2021–2032)
9.2 Latin America Neuropathy Pain Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Neuropathy Pain Treatment Market Size by Country (2021–2026)
9.4 Latin America Neuropathy Pain Treatment Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuropathy Pain Treatment Market Size (2021–2032)
10.2 Middle East & Africa Neuropathy Pain Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Neuropathy Pain Treatment Market Size by Country (2021–2026)
10.4 Middle East & Africa Neuropathy Pain Treatment Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Neuropathy Pain Treatment Introduction
11.1.4 Pfizer Revenue in Neuropathy Pain Treatment Business (2021–2026)
11.1.5 Pfizer Recent Development
11.2 Depomed
11.2.1 Depomed Company Details
11.2.2 Depomed Business Overview
11.2.3 Depomed Neuropathy Pain Treatment Introduction
11.2.4 Depomed Revenue in Neuropathy Pain Treatment Business (2021–2026)
11.2.5 Depomed Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Neuropathy Pain Treatment Introduction
11.3.4 Eli Lilly Revenue in Neuropathy Pain Treatment Business (2021–2026)
11.3.5 Eli Lilly Recent Development
11.4 Endo
11.4.1 Endo Company Details
11.4.2 Endo Business Overview
11.4.3 Endo Neuropathy Pain Treatment Introduction
11.4.4 Endo Revenue in Neuropathy Pain Treatment Business (2021–2026)
11.4.5 Endo Recent Development
11.5 Grünenthal Group
11.5.1 Grünenthal Group Company Details
11.5.2 Grünenthal Group Business Overview
11.5.3 Grünenthal Group Neuropathy Pain Treatment Introduction
11.5.4 Grünenthal Group Revenue in Neuropathy Pain Treatment Business (2021–2026)
11.5.5 Grünenthal Group Recent Development
11.6 Arbor Pharmaceuticals
11.6.1 Arbor Pharmaceuticals Company Details
11.6.2 Arbor Pharmaceuticals Business Overview
11.6.3 Arbor Pharmaceuticals Neuropathy Pain Treatment Introduction
11.6.4 Arbor Pharmaceuticals Revenue in Neuropathy Pain Treatment Business (2021–2026)
11.6.5 Arbor Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neuropathy Pain Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Calcium Channel Alpha 2-delta Ligands
Table 3. Key Players of Serotonin-norepinephrine Reuptake Inhibitors
Table 4. Key Players of Others
Table 5. Global Neuropathy Pain Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Neuropathy Pain Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Neuropathy Pain Treatment Market Size by Region (US$ Million), 2021–2026
Table 8. Global Neuropathy Pain Treatment Market Share by Region (2021–2026)
Table 9. Global Neuropathy Pain Treatment Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Neuropathy Pain Treatment Market Share by Region (2027–2032)
Table 11. Neuropathy Pain Treatment Market Trends
Table 12. Neuropathy Pain Treatment Market Drivers
Table 13. Neuropathy Pain Treatment Market Challenges
Table 14. Neuropathy Pain Treatment Market Restraints
Table 15. Global Neuropathy Pain Treatment Revenue by Players (US$ Million), 2021–2026
Table 16. Global Neuropathy Pain Treatment Market Share by Players (2021–2026)
Table 17. Global Top Neuropathy Pain Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Neuropathy Pain Treatment Revenue, 2025
Table 18. Ranking of Global Top Neuropathy Pain Treatment Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Neuropathy Pain Treatment Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Neuropathy Pain Treatment, Headquarters and Area Served
Table 21. Global Key Players of Neuropathy Pain Treatment, Products and Applications
Table 22. Global Key Players of Neuropathy Pain Treatment, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Neuropathy Pain Treatment Market Size by Type (US$ Million), 2021–2026
Table 25. Global Neuropathy Pain Treatment Revenue Market Share by Type (2021–2026)
Table 26. Global Neuropathy Pain Treatment Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Neuropathy Pain Treatment Revenue Market Share by Type (2027–2032)
Table 28. Global Neuropathy Pain Treatment Market Size by Application (US$ Million), 2021–2026
Table 29. Global Neuropathy Pain Treatment Revenue Market Share by Application (2021–2026)
Table 30. Global Neuropathy Pain Treatment Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Neuropathy Pain Treatment Revenue Market Share by Application (2027–2032)
Table 32. North America Neuropathy Pain Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Neuropathy Pain Treatment Market Size by Country (US$ Million), 2021–2026
Table 34. North America Neuropathy Pain Treatment Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Neuropathy Pain Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Neuropathy Pain Treatment Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Neuropathy Pain Treatment Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Neuropathy Pain Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Neuropathy Pain Treatment Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Neuropathy Pain Treatment Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Neuropathy Pain Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Neuropathy Pain Treatment Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Neuropathy Pain Treatment Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Neuropathy Pain Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Neuropathy Pain Treatment Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Neuropathy Pain Treatment Market Size by Country (US$ Million), 2027–2032
Table 47. Pfizer Company Details
Table 48. Pfizer Business Overview
Table 49. Pfizer Neuropathy Pain Treatment Product
Table 50. Pfizer Revenue in Neuropathy Pain Treatment Business (US$ Million), 2021–2026
Table 51. Pfizer Recent Development
Table 52. Depomed Company Details
Table 53. Depomed Business Overview
Table 54. Depomed Neuropathy Pain Treatment Product
Table 55. Depomed Revenue in Neuropathy Pain Treatment Business (US$ Million), 2021–2026
Table 56. Depomed Recent Development
Table 57. Eli Lilly Company Details
Table 58. Eli Lilly Business Overview
Table 59. Eli Lilly Neuropathy Pain Treatment Product
Table 60. Eli Lilly Revenue in Neuropathy Pain Treatment Business (US$ Million), 2021–2026
Table 61. Eli Lilly Recent Development
Table 62. Endo Company Details
Table 63. Endo Business Overview
Table 64. Endo Neuropathy Pain Treatment Product
Table 65. Endo Revenue in Neuropathy Pain Treatment Business (US$ Million), 2021–2026
Table 66. Endo Recent Development
Table 67. Grünenthal Group Company Details
Table 68. Grünenthal Group Business Overview
Table 69. Grünenthal Group Neuropathy Pain Treatment Product
Table 70. Grünenthal Group Revenue in Neuropathy Pain Treatment Business (US$ Million), 2021–2026
Table 71. Grünenthal Group Recent Development
Table 72. Arbor Pharmaceuticals Company Details
Table 73. Arbor Pharmaceuticals Business Overview
Table 74. Arbor Pharmaceuticals Neuropathy Pain Treatment Product
Table 75. Arbor Pharmaceuticals Revenue in Neuropathy Pain Treatment Business (US$ Million), 2021–2026
Table 76. Arbor Pharmaceuticals Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
Table 80. Authors List of This Report


List of Figures
Figure 1. Neuropathy Pain Treatment Picture
Figure 2. Global Neuropathy Pain Treatment Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Neuropathy Pain Treatment Market Share by Type: 2025 vs 2032
Figure 4. Calcium Channel Alpha 2-delta Ligands Features
Figure 5. Serotonin-norepinephrine Reuptake Inhibitors Features
Figure 6. Others Features
Figure 7. Global Neuropathy Pain Treatment Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Neuropathy Pain Treatment Market Share by Application: 2025 vs 2032
Figure 9. Retail Pharmacies Case Studies
Figure 10. Hospitals Case Studies
Figure 11. Others Case Studies
Figure 12. Neuropathy Pain Treatment Report Years Considered
Figure 13. Global Neuropathy Pain Treatment Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Neuropathy Pain Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Neuropathy Pain Treatment Market Share by Region: 2025 vs 2032
Figure 16. Global Neuropathy Pain Treatment Market Share by Players in 2025
Figure 17. Global Neuropathy Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Neuropathy Pain Treatment Revenue in 2025
Figure 19. North America Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Neuropathy Pain Treatment Market Share by Country (2021–2032)
Figure 21. United States Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Neuropathy Pain Treatment Market Share by Country (2021–2032)
Figure 25. Germany Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Neuropathy Pain Treatment Market Share by Region (2021–2032)
Figure 33. China Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Neuropathy Pain Treatment Market Share by Country (2021–2032)
Figure 41. Mexico Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Neuropathy Pain Treatment Market Share by Country (2021–2032)
Figure 45. Israel Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Neuropathy Pain Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Pfizer Revenue Growth Rate in Neuropathy Pain Treatment Business (2021–2026)
Figure 49. Depomed Revenue Growth Rate in Neuropathy Pain Treatment Business (2021–2026)
Figure 50. Eli Lilly Revenue Growth Rate in Neuropathy Pain Treatment Business (2021–2026)
Figure 51. Endo Revenue Growth Rate in Neuropathy Pain Treatment Business (2021–2026)
Figure 52. Grünenthal Group Revenue Growth Rate in Neuropathy Pain Treatment Business (2021–2026)
Figure 53. Arbor Pharmaceuticals Revenue Growth Rate in Neuropathy Pain Treatment Business (2021–2026)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies